Загрузка...
Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in Rats
OBJECTIVE: To seek efficient aldose reductase inhibitors (ARIs) with excellent in vitro and in vivo biological activities against rat galactosemic cataract. METHODS: The method was firstly optimized to screen strong ARIs from nonoriented synthetic compounds and natural extracts. Then, diosgenin was...
Сохранить в:
| Опубликовано в: : | J Diabetes Res |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5605930/ https://ncbi.nlm.nih.gov/pubmed/29038789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7309816 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|